SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : CLTR COULTER PHARMACEUTICAL
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: Pseudo Biologist who wrote (68)12/3/1997 1:20:00 PM
From: Grainne  Read Replies (2) of 666
 
Thank you very much for your detailed and coherent response to my medical questions. What do you think of Coulter as an investment, in the sense of timing? Do you think it will act like a typical biotech stock, in the sense of wild fluctuations, with many more buying opportunities before Bexxar affects the bottom line in 1999 or 2000, or do you think this stock's share price will continue to climb fairly rapidly and predictably?

I have to say, from your explanation, that if I needed one of these drugs, the prospect of Bexxar being used at an earlier disease stage would be very appealing, and that overall I think Bexxar seems to offer more hope.
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  

HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2025 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News